These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 14499246)

  • 21. Is decreased HIV-1 infectivity of placental macrophages caused by high levels of beta-chemokines?
    Meléndez J; García V; Sánchez E; Delgado R; Torres G; Meléndez-Guerrero LM
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL51-9. PubMed ID: 11936874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage-tropic HIV induces and exploits dendritic cell chemotaxis.
    Lin CL; Sewell AK; Gao GF; Whelan KT; Phillips RE; Austyn JM
    J Exp Med; 2000 Aug; 192(4):587-94. PubMed ID: 10952729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS).
    McDermott DH; Zimmerman PA; Guignard F; Kleeberger CA; Leitman SF; Murphy PM
    Lancet; 1998 Sep; 352(9131):866-70. PubMed ID: 9742978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
    Lee S; Lapham CK; Chen H; King L; Manischewitz J; Romantseva T; Mostowski H; Stantchev TS; Broder CC; Golding H
    J Virol; 2000 Jun; 74(11):5016-23. PubMed ID: 10799575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic acceleration of AIDS progression by a promoter variant of CCR5.
    Martin MP; Dean M; Smith MW; Winkler C; Gerrard B; Michael NL; Lee B; Doms RW; Margolick J; Buchbinder S; Goedert JJ; O'Brien TR; Hilgartner MW; Vlahov D; O'Brien SJ; Carrington M
    Science; 1998 Dec; 282(5395):1907-11. PubMed ID: 9836644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New CCR5 variants associated with reduced HIV coreceptor function in southeast Asia.
    Capoulade-Métay C; Ma L; Truong LX; Dudoit Y; Versmisse P; Nguyen NV; Nguyen M; Scott-Algara D; Barré-Sinoussi F; Debré P; Bismuth G; Pancino G; Theodorou I
    AIDS; 2004 Nov; 18(17):2243-52. PubMed ID: 15577536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort.
    Morawetz RA; Rizzardi GP; Glauser D; Rutschmann O; Hirschel B; Perrin L; Opravil M; Flepp M; von Overbeck J; Glauser MP; Ghezzi S; Vicenzi E; Poli G; Lazzarin A; Pantaleo G
    Eur J Immunol; 1997 Dec; 27(12):3223-7. PubMed ID: 9464809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
    Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M
    Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphism in the CCR5 gene promoter and HIV-1 infection in North Indians.
    Kaur G; Singh P; Rapthap CC; Kumar N; Vajpayee M; Sharma SK; Wanchu A; Mehra NK
    Hum Immunol; 2007 May; 68(5):454-61. PubMed ID: 17462514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells.
    Verani A; Scarlatti G; Comar M; Tresoldi E; Polo S; Giacca M; Lusso P; Siccardi AG; Vercelli D
    J Exp Med; 1997 Mar; 185(5):805-16. PubMed ID: 9120386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
    Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F
    J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene polymorphisms in CCR5, CCR2, SDF1 and RANTES among Chinese Han population with HIV-1 infection.
    Li H; Liu TJ; Hong ZH
    Infect Genet Evol; 2014 Jun; 24():99-104. PubMed ID: 24650919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences.
    Heggelund L; Damås JK; Yndestad A; Holm AM; Mūller F; Lien E; Espevik T; Aukrust P; Frøland SS
    Clin Exp Immunol; 2004 Oct; 138(1):116-21. PubMed ID: 15373913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines.
    Paxton WA; Liu R; Kang S; Wu L; Gingeras TR; Landau NR; Mackay CR; Koup RA
    Virology; 1998 Apr; 244(1):66-73. PubMed ID: 9581779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased CCR5 expression with decreased beta chemokine secretion in Ethiopians: relevance to AIDS in Africa.
    Kalinkovich A; Weisman Z; Leng Q; Borkow G; Stein M; Greenberg Z; Zlotnikov S; Eitan S; Bentwich Z
    J Hum Virol; 1999; 2(5):283-9. PubMed ID: 10551734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro.
    Wu L; Paxton WA; Kassam N; Ruffing N; Rottman JB; Sullivan N; Choe H; Sodroski J; Newman W; Koup RA; Mackay CR
    J Exp Med; 1997 May; 185(9):1681-91. PubMed ID: 9151905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
    Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G
    Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy.
    O'Brien TR; McDermott DH; Ioannidis JP; Carrington M; Murphy PM; Havlir DV; Richman DD
    AIDS; 2000 May; 14(7):821-6. PubMed ID: 10839590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor.
    Weissman D; Rabin RL; Arthos J; Rubbert A; Dybul M; Swofford R; Venkatesan S; Farber JM; Fauci AS
    Nature; 1997 Oct; 389(6654):981-5. PubMed ID: 9353123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
    Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E
    J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.